Phase 2, Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study of INV-102 Ophthalmic Solution in Adult Subjects With Moderate to Severe Dry Eye Disease
Latest Information Update: 22 Jul 2024
At a glance
- Drugs INV-102-Invirsa (Primary) ; INV-102-Invirsa (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Invirsa
Most Recent Events
- 12 Jul 2024 Status changed from recruiting to completed.
- 12 Apr 2024 Status changed from planning to recruiting.
- 27 Jun 2023 New trial record